Latest Article:
Bionique Holds Groundbreaking Ceremony for Building Expansion
The groundbreaking ceremony held on May 14, 2024 marks a significant investment in Bionique’s continued growth and commitment to progress. The project will enable the company to expand its biosafety testing services to better serve clients and further support the discovery and development of biologics.
Read Article
Bionique Welcomes New Member to Leadership Team
Lori Daane, PhD joins Bionique as its new CSO effective April 1, 2024. She has over thirty years of experience and is uniquely positioned to lead Bionique’s service portfolio expansion, enabling the organization to solve for the biosafety testing needs associated with the development, manufacturing, and release of biologics inclusive of cell & gene therapies.
Read Article
Research, References, and Regulatory Guidelines
At Bionique, it’s crucial to have a thorough understanding of mycoplasma and its implications in your products. We’ve compiled a list of some of the best resources to learn more about mycoplasma.
Read Article
Bionique Receives Asahi Kasei Bioprocess Division Award
Bionique is excited to announce that its team received the 2023 Asahi Kasei Bioprocess Division Award. This award recognizes innovation and outstanding achievement. Congratulations to Kevin Susice, Eric Damour, Brandy VanBuskirk, and Doug Crowell for their remarkable contributions to introducing automation in testing!
Read Article
Bionique to Expand After Acquisition by Asahi Kasei Medical
On December 15, 2021, Bionique announced it has been acquired by a subsidiary of Japan-based healthcare pioneer Asahi Kasei Medical Co., Ltd. Bionique joins Austria-based viral and prion safety testing services expert ViruSure GmbH as part of the global biosafety testing services unit of Asahi Kasei Medical’s Bioprocess Division. Both Bionique and ViruSure will continue […]
Read Article
Bionique in Association with ThermoFisher and American Pharmaceutical Review Present: Key Considerations for Implementing Rapid Microbial Methods for Mycoplasma Detection.
This white paper explains the importance of demonstrating product-specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence. Rapid microbial methods are increasingly being used by cell therapy developers motivated by particularly short production schedules and product shelf life, and has grown to include raw […]
Read Article
Bionique’s Research Presented in Advances in Biotechnology & Microbiology
Research conducted at Bionique Testing Laboratories was published in an article that studies the impact of aerobicity on colony growth of various mollicutes, including mycoplasma, on agar in order to confirm the optimal oxygen content for colony growth for isolation of mycoplasma from cell cultures for routine subcultivation. The purpose of the study was to […]
Read ArticleWant to read the latest about Bionique?
Read our latest news and announcements.